On the public citation graph

In silico and in vitro screening of FDA-approved drugs for potential repurposing against tuberculosis

0 signed · 41 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.antiviral.2009.10.002openalex-snapshot
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
inferredcites →https://doi.org/10.1016/j.cell.2011.02.022openalex-snapshot
Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
inferredcites →https://doi.org/10.1016/j.compbiolchem.2005.07.001openalex-snapshot
Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis
inferredcites →https://doi.org/10.1016/j.drudis.2015.05.001openalex-snapshot
Drug repositioning and repurposing: terminology and definitions in literature
inferredcites →https://doi.org/10.1016/j.ijid.2014.12.031openalex-snapshot
Repurposing—a ray of hope in tackling extensively drug resistance in tuberculosis
inferredcites →https://doi.org/10.1016/j.jmb.2010.04.064openalex-snapshot
M. tuberculosis Pantothenate Kinase: Dual Substrate Specificity and Unusual Changes in Ligand Locations
inferredcites →https://doi.org/10.1016/j.jtbi.2009.09.029openalex-snapshot
Protein interaction network analysis—Approach for potential drug target identification in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1016/j.mimet.2008.01.005openalex-snapshot
Construction and evaluation of luciferase reporter phages for the detection of active and non-replicating tubercle bacilli
inferredcites →https://doi.org/10.1016/j.tube.2008.02.007openalex-snapshot
Characterization of temperate phage Che12 and construction of a new tool for diagnosis of tuberculosis
inferredcites →https://doi.org/10.1016/j.tube.2015.11.009openalex-snapshot
A whole genome bioinformatic approach to determine potential latent phase specific targets in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1021/bi301387mopenalex-snapshot
The Substrate Capture Mechanism of Mycobacterium tuberculosis Anthranilate Phosphoribosyltransferase Provides a Mode for Inhibition
inferredcites →https://doi.org/10.1021/jm400856topenalex-snapshot
Polypharmacology – Foe or Friend?
inferredcites →https://doi.org/10.1021/jm5006463openalex-snapshot
Polypharmacology: Challenges and Opportunities in Drug Discovery
inferredcites →https://doi.org/10.1038/ja.2014.131openalex-snapshot
Antimycobacterial activity of DNA intercalator inhibitors of Mycobacterium tuberculosis primase DnaG
inferredcites →https://doi.org/10.1038/nrd1468openalex-snapshot
Drug repositioning: identifying and developing new uses for existing drugs
inferredcites →https://doi.org/10.1038/nrd4707openalex-snapshot
Pioneering government-sponsored drug repositioning collaborations: progress and learning
inferredcites →https://doi.org/10.1046/j.1365-2958.2003.03425.xopenalex-snapshot
Genes required for mycobacterial growth defined by high density mutagenesis
inferredcites →https://doi.org/10.1073/pnas.2134250100openalex-snapshot
Genetic requirements for mycobacterial survival during infection
inferredcites →https://doi.org/10.1093/infdis/jit550openalex-snapshot
Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation
inferredcites →https://doi.org/10.1093/infdis/jiu095openalex-snapshot
Verapamil, and Its Metabolite Norverapamil, Inhibit Macrophage-induced, Bacterial Efflux Pump-mediated Tolerance to Multiple Anti-tubercular Drugs
inferredcites →https://doi.org/10.1093/jac/dks405openalex-snapshot
Is repositioning of drugs a viable alternative in the treatment of tuberculosis?
inferredcites →https://doi.org/10.1093/jac/dku166openalex-snapshot
Simvastatin increases the in vivo activity of the first-line tuberculosis regimen
inferredcites →https://doi.org/10.1099/mic.0.040717-0openalex-snapshot
Essentiality and functional analysis of type I and type III pantothenate kinases of Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1107/s0907444906012728openalex-snapshot
Invariance and variability in bacterial PanK: a study based on the crystal structure ofMycobacterium tuberculosisPanK
inferredcites →https://doi.org/10.1126/science.1167498openalex-snapshot
Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1126/scitranslmed.3009885openalex-snapshot
Metformin as adjunct antituberculosis therapy
inferredcites →https://doi.org/10.1128/aac.01826-13openalex-snapshot
Statins Increase Rifampin Mycobactericidal Effect
inferredcites →https://doi.org/10.1128/aac.44.12.3285-3287.2000openalex-snapshot
Early Bactericidal Activity of Paromomycin (Aminosidine) in Patients with Smear-Positive Pulmonary Tuberculosis
inferredcites →https://doi.org/10.1128/iai.69.2.1442-1150.2001openalex-snapshot
Characterization of Auxotrophic Mutants of Mycobacterium tuberculosis and Their Potential as Vaccine Candidates
inferredcites →https://doi.org/10.1155/2014/812974openalex-snapshot
Bioactive Potential of Actinomycetes from Less Explored Ecosystems against Mycobacterium tuberculosis and Other Nonmycobacterial Pathogens
inferredcites →https://doi.org/10.1164/rccm.201304-0650ocopenalex-snapshot
Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor
inferredcites →https://doi.org/10.1183/13993003/erj.38.suppl_55.393openalex-snapshot
The 2011 update of the World Health Organization guidelines for the programmatic management of drug-resistant tuberculosis
inferredcites →https://doi.org/10.1186/1752-0509-2-109openalex-snapshot
targetTB: A target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis
inferredcites →https://doi.org/10.2174/15680266113136660166openalex-snapshot
Repurposed Drugs in Metabolic Disorders
inferredcites →https://doi.org/10.3978/j.issn.2305-5839.2014.06.01openalex-snapshot
Metformin in cancer prevention and therapy.

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1007/978-981-32-9413-4_25openalex-snapshot
Challenges and Advances in TB Drug Discovery
inferred← citeshttps://doi.org/10.1007/978-981-92-0256-0_9openalex-snapshot
Drug Repositioning: An Alternative Strategy to Tackle Multidrug-Resistant M. tuberculosis
inferred← citeshttps://doi.org/10.1007/978-981-96-4154-3_26openalex-snapshot
Drug Discovery and Computational Strategies in Multi-Drug-Resistant Tuberculosis
inferred← citeshttps://doi.org/10.1021/acsomega.2c05511openalex-snapshot
Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade
inferred← citeshttps://doi.org/10.1038/s41598-019-43201-xopenalex-snapshot
Combination of Repurposed Drug Diosmin with Amoxicillin-Clavulanic acid Causes Synergistic Inhibition of Mycobacterial Growth
inferred← citeshttps://doi.org/10.21786/bbrc/13.3/39openalex-snapshot
Luciferase Reporter Phage Assay for Anti Tuberculosis Screening: Current Status and Challenges
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.